Valneva and Pfizer Announce Promising Lyme Disease Vaccine Results
Sep 4, 2024
Valneva Stock Market Invest
Valneva Obtains $41.3 Million Grant from CEPI for Chikungunya Vaccine Access Expansion
Jul 22, 2024
Valneva Receives Major Grant from CEPI to Enhance Global Accessibility to Chikungunya Vaccine
Jul 22, 2024
Valneva Announces Approval of Shareholder Resolutions and Welcomes New Board Member
Jun 26, 2024
Valneva SE Announces Documentation for Shareholder Meeting and Shares Corporate Update
Jun 5, 2024
Valneva SE to Participate in Major Healthcare Investor Conferences
Mar 4, 2024
EMA Initiates Expedited Review of Valneva's Candidate Chikungunya Vaccine
Nov 28, 2023